SQRDL Antibody

What is SQRDL/SQOR and what is its primary function in cellular metabolism?

SQRDL (Sulfide:quinone oxidoreductase, mitochondrial) is an essential enzyme that catalyzes the oxidation of hydrogen sulfide with the help of quinones, such as ubiquinone-10, producing thiosulfate and ultimately sulfane (molecular sulfur) atoms. It requires an additional electron acceptor, which in vivo is believed to be glutathione . SQRDL is localized in the mitochondria and plays a crucial role in H₂S signaling within discrete populations of neurons, oligodendrocytes, and endothelial cells . Although the SQRDL precursor protein has a molecular weight of 50 kDa, western blot typically detects a prominent band at approximately 46 kDa due to the cleavage of an N-terminal targeting sequence during mitochondrial import .

What criteria should researchers consider when selecting an anti-SQRDL antibody for specific experimental applications?

When selecting an anti-SQRDL antibody, researchers should consider:

• Application compatibility: Verify the antibody has been validated for your intended application (WB, IHC, ICC/IF, etc.)

• Species reactivity: Ensure the antibody recognizes SQRDL in your experimental species (human, mouse, rat, etc.)

• Clonality: Choose between polyclonal (recognizing multiple epitopes, potentially higher sensitivity) or monoclonal (higher specificity)

• Immunogen region: Consider whether the antibody targets full-length protein or specific regions (C-terminal, middle region) depending on your experimental questions

• Validation data: Review the manufacturer's validation data showing relevant applications and expected molecular weight (typically 50 kDa)

How can researchers effectively optimize western blot protocols for SQRDL detection given its mitochondrial localization?

Optimizing western blot for SQRDL requires specific considerations due to its mitochondrial localization:

• Sample preparation: Use mitochondrial extraction protocols to enrich for SQRDL. Standard RIPA buffer can work, but specialized mitochondrial isolation may increase sensitivity .

• Denaturation conditions: Use reducing conditions (β-mercaptoethanol or DTT) and heat samples at 95°C for 5 minutes to fully denature the protein.

• Gel percentage optimization: 10-12% SDS-PAGE gels are optimal for resolving the 46-50 kDa SQRDL protein .

• Transfer conditions: For mitochondrial proteins, semi-dry transfer systems with methanol-containing buffers often provide better results than wet transfer systems.

• Blocking optimization: Test both BSA and non-fat milk for blocking. Some mitochondrial epitopes are masked by milk proteins .

• Antibody dilution optimization: Begin with manufacturer's recommended dilution (typically 1:1000-1:4000 for WB) and adjust based on signal-to-noise ratio .

• Loading controls: Use mitochondrial-specific controls (e.g., VDAC/Porin) rather than cytosolic controls like GAPDH or β-actin when working with mitochondrial preparations .

What approaches can be used to validate SQRDL antibody specificity in research applications?

Multiple validation approaches should be employed to ensure SQRDL antibody specificity:

• Knockout/knockdown validation: The gold standard approach involves comparing antibody reactivity in wild-type versus SQRDL knockout or knockdown samples .

• Peptide competition assay: Pre-incubate antibody with excess immunizing peptide before application to verify that specific binding is blocked.

• Multiple antibody approach: Use antibodies from different sources targeting different epitopes to confirm consistency of results .

• Molecular weight verification: Confirm that the detected band is at the expected molecular weight (46-50 kDa) .

• Subcellular fractionation: Verify that SQRDL is detected primarily in mitochondrial fractions and not in cytosolic or nuclear extracts.

• Recombinant protein control: Include purified recombinant SQRDL protein as a positive control .

• Cross-reactivity assessment: Test in multiple species to verify the expected pattern of evolutionary conservation .

What are the optimal conditions for immunohistochemical detection of SQRDL in formalin-fixed, paraffin-embedded tissues?

For optimal IHC detection of SQRDL in FFPE tissues:

• Sectioning and preparation: Use 4-5 μm sections on positively charged slides.

• Antigen retrieval methods:

  • Heat-mediated antigen retrieval in EDTA buffer (pH 8.0) is recommended for most antibodies

  • Alternatively, citrate buffer (pH 6.0) can be used

  • Enzyme antigen retrieval may be necessary for some tissues

• Blocking conditions: 10% normal goat serum is effective for reducing background .

• Primary antibody incubation:

  • Dilution: 1:20-1:50 for most SQRDL antibodies

  • Incubation: Overnight at 4°C for optimal results

• Detection systems:

  • For chromogenic detection: HRP-conjugated secondary antibodies with DAB substrate work well

  • For fluorescent detection: DyLight®550/488 conjugated secondary antibodies provide good signal-to-noise ratio

• Counterstaining: Hematoxylin for chromogenic detection; DAPI for fluorescent detection.

• Tissues with high expression: Liver, colon, brain, testis, lung, and spleen show strong SQRDL expression and can serve as positive controls .

How should researchers troubleshoot inconsistent SQRDL immunofluorescence staining patterns?

When troubleshooting inconsistent SQRDL immunofluorescence patterns:

• Fixation optimization:

  • Test different fixatives (4% PFA, methanol, acetone)

  • Optimize fixation duration (10-20 minutes)

  • For mitochondrial proteins like SQRDL, glutaraldehyde may improve structural preservation

• Permeabilization protocol:

  • Ensure adequate permeabilization for mitochondrial access (0.1-0.5% Triton X-100 or 0.05% saponin)

  • Optimize permeabilization time (5-15 minutes)

• Antibody concentration gradient:

  • Perform titration series (1:50, 1:100, 1:200, 1:500)

  • Compare signal-to-noise ratio at each dilution

• Mitochondrial colocalization:

  • Use mitochondrial markers (MitoTracker, TOM20, COXIV) to confirm proper subcellular localization

  • Employ super-resolution microscopy for detailed colocalization studies

• Signal amplification strategies:

  • Consider tyramide signal amplification for weak signals

  • Test biotin-streptavidin systems for enhanced detection

• Antigen accessibility:

  • Try alternative epitope retrieval methods

  • Use detergents specific for mitochondrial membrane permeabilization

• Cross-validation:

  • Confirm staining pattern with multiple SQRDL antibodies targeting different epitopes

How can SQRDL antibodies be used to investigate hydrogen sulfide signaling pathways in neurodegenerative disorders?

SQRDL antibodies provide valuable tools for investigating H₂S signaling in neurodegenerative contexts:

• Expression mapping in neural tissues:

  • Use immunohistochemistry to map SQRDL expression across brain regions in normal versus pathological specimens

  • Analyze cell-type specific expression within neurons, oligodendrocytes, and astrocytes using dual immunofluorescence

• Oxidative stress correlation studies:

  • Measure SQRDL levels via western blot in relation to oxidative stress markers

  • Correlate SQRDL expression with disease progression in neurodegenerative models

• Mitochondrial dysfunction assessment:

  • Use SQRDL as a marker for mitochondrial integrity in neurodegenerative conditions

  • Examine colocalization with mitochondrial dynamics markers (fission/fusion proteins)

• Therapeutic intervention monitoring:

  • Monitor SQRDL expression changes following treatment with H₂S donors or modulators

  • Use flow cytometry with SQRDL antibodies to quantify changes in neuronal cell models

• Single-cell analysis:

  • Employ SQRDL antibodies in single-cell protein profiling of neural populations

  • Correlate with other H₂S metabolic enzymes (CBS, CSE, 3-MST)

• Animal model validation:

  • Compare human and rodent SQRDL expression patterns in corresponding disease models

  • Validate antibody cross-reactivity between species before comparative studies

What strategies can be employed to analyze SQRDL post-translational modifications using available antibodies?

Analyzing SQRDL post-translational modifications requires specialized approaches:

• Phosphorylation analysis:

  • Perform immunoprecipitation with SQRDL antibodies followed by phospho-specific staining

  • Use Phos-tag gels to separate phosphorylated from non-phosphorylated forms

  • Combine with phosphatase inhibitor treatments to preserve modifications

• Ubiquitination/SUMOylation detection:

  • Perform sequential immunoprecipitation with SQRDL antibodies followed by ubiquitin/SUMO antibodies

  • Use denaturing conditions to disrupt protein complexes and reveal direct modifications

• Redox state analysis:

  • Combine non-reducing and reducing gel conditions to detect disulfide-bonded forms

  • Use alkylating agents to trap reactive cysteines before analysis

• Mitochondrial processing verification:

  • Compare antibodies targeting different epitopes to detect processing events

  • Analyze N-terminal cleavage by comparing full-length vs. processed form ratios

• Mass spectrometry validation:

  • Use immunoprecipitation with SQRDL antibodies as enrichment strategy

  • Perform LC-MS/MS analysis to identify specific modification sites

• In vitro modification assays:

  • Express recombinant SQRDL and perform in vitro modification assays

  • Use modified protein as positive control for antibody validation

How can researchers effectively integrate SQRDL antibody-based detection with transcriptomic and metabolomic approaches?

Integrating SQRDL protein detection with other omics approaches enables comprehensive pathway analysis:

• Correlation of protein and mRNA levels:

  • Compare SQRDL protein levels (western blot/IHC) with mRNA expression (qPCR/RNA-seq)

  • Analyze post-transcriptional regulation by calculating protein-to-mRNA ratios

• Sulfur metabolite correlation studies:

  • Measure hydrogen sulfide, thiosulfate, and sulfite levels via metabolomics

  • Correlate SQRDL protein levels with metabolite abundance

  • Use SQRDL antibodies to isolate SQRDL-associated protein complexes for activity assays

• Multi-omics data integration framework:

  • Use computational tools to integrate protein, transcript, and metabolite data

  • Apply network analysis to position SQRDL within cellular sulfur metabolism

• Single-cell multi-omics approaches:

  • Combine SQRDL immunostaining with single-cell RNA-seq in CITE-seq approaches

  • Analyze cell-type specific correlations between protein and transcript

• Spatial transcriptomics integration:

  • Align SQRDL immunohistochemistry with spatial transcriptomics data

  • Generate spatial maps of protein-mRNA correlations

• Environmental stress response studies:

  • Monitor SQRDL protein, mRNA, and H₂S metabolites during hypoxia, oxidative stress

  • Create temporal profiles of mitochondrial sulfide metabolism during stress response

What methodological considerations are important when using SQRDL antibodies in tissue microarrays for large-scale clinical studies?

When using SQRDL antibodies in tissue microarrays (TMAs) for clinical studies:

• Antibody validation for TMA application:

  • Perform preliminary full-section validation before TMA analysis

  • Validate staining consistency across multiple tissue types and fixation conditions

  • Test multiple SQRDL antibodies to select optimal performer

• TMA design considerations:

  • Include positive controls (liver, colon) and negative controls on each TMA

  • Use triplicate cores per case to account for heterogeneity

  • Include internal reference tissues for normalization

• Staining protocol standardization:

  • Develop automated staining protocols to minimize batch effects

  • Use optimized antigen retrieval (EDTA buffer pH 8.0 or citrate buffer pH 6.0)

  • Apply chromogenic detection systems for long-term stability

• Quantification methods:

  • Implement digital pathology algorithms for unbiased quantification

  • Validate scoring metrics (H-score, Allred score) for SQRDL expression

  • Use machine learning approaches for pattern recognition beyond intensity

• Data analysis approaches:

  • Correlate SQRDL expression with clinical parameters and outcomes

  • Perform multivariate analysis adjusting for confounding variables

  • Consider tissue and cell-type specific expression patterns in interpretation

• Quality control measures:

  • Monitor antibody lot-to-lot variation with standardized positive controls

  • Implement regular staining quality assessments

  • Include methodological variables in statistical models

How can super-resolution microscopy be optimized for studying SQRDL's precise mitochondrial localization?

Optimizing super-resolution microscopy for SQRDL mitochondrial localization:

• Sample preparation considerations:

  • Use thin sections (≤100 nm for STORM/PALM)

  • Apply specialized fixation protocols to preserve mitochondrial ultrastructure

  • Consider expansion microscopy for enhanced resolution of mitochondrial compartments

• Antibody selection and labeling:

  • Choose bright, photostable fluorophores (Alexa Fluor 647 for STORM)

  • Use F(ab) fragments or nanobodies for reduced linkage error

  • Validate specificity with appropriate controls (knockout tissues/cells)

• Mitochondrial co-labeling strategy:

  • Apply sequential labeling for multiple mitochondrial markers

  • Use spectrally distinct fluorophores for outer membrane, inner membrane, and matrix

  • Include functional markers (membrane potential dyes) for subpopulation analysis

• Imaging parameters optimization:

  • Adjust laser power, exposure time, and buffer composition for optimal photoswitching

  • Use astigmatism or biplane approaches for improved axial resolution

  • Implement drift correction with fiducial markers

• Data analysis approaches:

  • Apply specialized clustering algorithms to analyze SQRDL distribution

  • Quantify distance from inner/outer membranes precisely

  • Correlate SQRDL clusters with functional mitochondrial domains

• Validation with complementary techniques:

  • Confirm localization with immuno-electron microscopy

  • Correlate with biochemical fractionation studies of mitochondrial compartments

What are the most effective approaches for analyzing SQRDL conformational changes during hydrogen sulfide metabolism?

Analyzing SQRDL conformational changes during H₂S metabolism:

• Proximity labeling approaches:

  • Use SQRDL antibodies to immunoprecipitate the enzyme under different metabolic states

  • Apply limited proteolysis to detect conformational differences

  • Compare trypsin digestion patterns between active and inactive states

• Conformational antibody development:

  • Generate antibodies that specifically recognize active vs. inactive conformations

  • Validate using purified protein in defined redox states

  • Apply to tissues/cells under varying H₂S concentrations

• FRET-based sensors:

  • Design FRET sensors with SQRDL antibody-derived binding domains

  • Monitor conformational changes in real-time in live cells

  • Calibrate signals with known H₂S concentrations

• Hydrogen-deuterium exchange mass spectrometry:

  • Perform H/D exchange on purified SQRDL in different functional states

  • Identify regions with differential exchange rates

  • Correlate with antibody epitope accessibility

• Cross-linking coupled to mass spectrometry:

  • Apply chemical cross-linkers to capture transient conformations

  • Use SQRDL antibodies for enrichment before analysis

  • Map distance constraints between different domains

• Computational modeling validation:

  • Generate structural models of different SQRDL conformational states

  • Predict antibody epitope accessibility in each state

  • Validate predictions with experimental antibody binding studies

How might SQRDL antibodies be utilized in developing novel biomarkers for mitochondrial dysfunction in metabolic diseases?

SQRDL antibodies offer promising avenues for developing mitochondrial dysfunction biomarkers:

• Circulating SQRDL detection methods:

  • Develop sensitive ELISA/immunoassays using validated antibodies

  • Evaluate SQRDL in extracellular vesicles as tissue-specific indicators

  • Correlate with established markers of mitochondrial damage

• Tissue-specific expression profiles:

  • Map SQRDL expression changes across metabolic disease progression

  • Identify tissue-specific patterns correlating with pathology

  • Develop immunohistochemistry-based prognostic indicators

• SQRDL post-translational modification signatures:

  • Characterize disease-specific PTM patterns

  • Develop modification-specific antibodies as targeted biomarkers

  • Correlate modifications with enzyme activity and H₂S metabolism

• Companion diagnostics development:

  • Utilize SQRDL antibodies in predictive assays for therapeutic response

  • Monitor treatment efficacy in mitochondrial-targeted interventions

  • Integrate with other mitochondrial health indicators

• Non-invasive imaging applications:

  • Explore antibody derivatives for PET/SPECT imaging of mitochondrial integrity

  • Develop targeted nanoparticles conjugated with SQRDL antibody fragments

  • Validate in relevant animal models of metabolic dysfunction

• Multi-parameter flow cytometry applications:

  • Develop blood cell SQRDL analysis as accessible biomarker

  • Correlate with functional metabolic parameters

  • Establish reference ranges for clinical application

What methodological advances are needed to better characterize SQRDL interactions with other hydrogen sulfide metabolism enzymes?

Advancing SQRDL interaction analysis requires methodological innovations:

• Proximity labeling technologies:

  • Apply BioID, APEX, or TurboID fusions with SQRDL

  • Identify proximal proteins in living cells

  • Validate interactions with co-immunoprecipitation using SQRDL antibodies

• Advanced co-immunoprecipitation approaches:

  • Develop optimized protocols preserving mitochondrial protein complexes

  • Apply quantitative mass spectrometry to identify interaction dynamics

  • Use crosslinking to capture transient interactions

• Protein complementation assays:

  • Design split reporter systems for SQRDL and potential partners

  • Monitor interactions in real-time in live cells

  • Validate with traditional antibody-based approaches

• Super-resolution co-localization analysis:

  • Apply multi-color STORM/PALM with SQRDL and partner antibodies

  • Quantify nanoscale co-localization patterns

  • Develop advanced statistical frameworks for interaction probability

• Single-molecule tracking:

  • Label SQRDL with quantum dots or organic dyes

  • Track dynamic interactions with other labeled proteins

  • Analyze diffusion patterns indicating complex formation

• In situ proximity ligation assay optimization:

  • Develop PLA protocols for SQRDL and H₂S enzymes

  • Apply to tissue sections to preserve native context

  • Quantify interaction frequency in different physiological states